![Andrey Aleksandrovich Putilov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrey Aleksandrovich Putilov
Presidente presso SynBio LLC
Provenienza dei contatti di primo grado di Andrey Aleksandrovich Putilov
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
SynBio LLC
![]() SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
PET-Technology OOO
![]() PET-Technology OOO Medical SpecialtiesHealth Technology PET-Technology OOO operates as a network of nuclear medicine centers. It provides positron emission and computerized tomography, as well as cyberknife treatment services. The company was founded on September 1, 2011 and is headquartered in Moscow, Russia.
2
| Subsidiary | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrey Aleksandrovich Putilov tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University College London | College/University | Corporate Officer/Principal | |
Xenetic Biosciences (UK) Ltd.
![]() Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Moscow State Institute of Radio-Engineering Elec & Automation | College/University | Doctorate Degree | |
FDS Pharma Associates Ltd. | Director/Board Member | ||
EPhaG AS
![]() EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Drugstore Chains | Director/Board Member | |
PHARMSYNTHEZ | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Rusnano OJSC
![]() Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Miscellaneous Commercial Services | Chief Investment Officer | |
HUMAN STEM CELLS INSTITUTE | Medical/Nursing Services | Director/Board Member | |
Peri-Ness Technologies Ltd.
![]() Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Pharmaceuticals: Major | Director/Board Member | |
RUSNANO Projects
![]() RUSNANO Projects Investment ManagersFinance Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia. | Investment Managers | Director/Board Member | |
NTpharma LLC
![]() NTpharma LLC Pharmaceuticals: MajorHealth Technology NTpharma LLC develops nanotechnology-based flu vaccines and immune activators. It employs non-replicating genetically modified viruses carrying genes for target proteins to activate the immune system. The company was founded in 2010 and is headquartered in Moscow, Russia. | Pharmaceuticals: Major | Director/Board Member | |
Mitotech LLC
![]() Mitotech LLC Pharmaceuticals: MajorHealth Technology Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia. | Pharmaceuticals: Major | Director/Board Member | |
Kevelt AS
![]() Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Pharmaceuticals: Major | Director/Board Member | |
H & H LLC | Director/Board Member | ||
Pharmavit Holding | Corporate Officer/Principal | ||
FDS Pharma LLP
![]() FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Trackpore Technology CJSC
![]() Trackpore Technology CJSC Medical/Nursing ServicesHealth Services Trackpore Technology CJSC provides medical equipment for membrane plasmapheresis. It offers cycle of production from development to manufacture of equipment and consumables for procedures of membrane plasmapheresis and cascade plasma filtration. The company was founded in 1998 and is headquartered in Moscow, Russia. | Medical/Nursing Services | Director/Board Member | |
Nanoderm-Profi OOO
![]() Nanoderm-Profi OOO Specialty StoresRetail Trade Nanoderm-Profi OOO develops and manufactures anti-aging cosmetics. The firm develops and implements nanotechnologies in the field of dermatology and cosmetology and produces cosmetics under the brand NanoDerm. The company was founded in 2011 and is headquartered in Moscow, Russia. | Specialty Stores | Director/Board Member | |
Mechnikov St Petersburg State Medical Academy | College/University | Undergraduate Degree | |
RMI Partners OOO
![]() RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Investment Managers | Director/Board Member | |
Nanolek Holding Ltd.
![]() Nanolek Holding Ltd. BiotechnologyHealth Technology Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services. | Biotechnology | Director/Board Member | |
NovaMedica LLC
![]() NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Pharmaceuticals: Major | Director/Board Member | |
XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Economics & Energy | College/University | Undergraduate Degree | |
Rusnano Management Co. LLC
![]() Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Investment Managers | Chief Investment Officer | |
Tsentr PETAR LLC | Director/Board Member | ||
RusnanoMedInvest LLC
![]() RusnanoMedInvest LLC Financial ConglomeratesFinance RusnanoMedInvest LLC provides investment services. | Financial Conglomerates | Director/Board Member | |
Pavlov First Saint Petersburg State Medical University | College/University | Undergraduate Degree | |
The School of Pharmacy University of London | College/University | Graduate Degree | |
NanoBrachiTech CJSC
![]() NanoBrachiTech CJSC Medical DistributorsDistribution Services NanoBrachyTech CJSC engages in development of nanotechnologies for treatment of cancer. It implements a project on production of micro sources and nanostructures for brachytherapy, based on silicon and phosphorus alloys, for treatment of primary and metastatic liver and pancreatic cancer. The company was founded on June 30, 2009 and is headquartered in Dubna, Russia. | Medical Distributors | Director/Board Member | |
CLS THERAPEUTICS, INC. | Director/Board Member | ||
SANTERSUS AG
![]() SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Medical Specialties | Founder |
Statistiche
Distribuzione geografica
Russia | 22 |
Regno Unito | 5 |
Estonia | 3 |
Stati Uniti | 3 |
Israele | 2 |
Settori
Health Technology | 12 |
Consumer Services | 7 |
Finance | 5 |
Retail Trade | 3 |
Health Services | 3 |
Posizioni
Director/Board Member | 34 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 4 |
Chief Executive Officer | 3 |
Chief Investment Officer | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Andrey Aleksandrovich Putilov
- Connessioni Società